Evidence map›Paper›PMID 32451471›Full record

ArticleNature microbiology2020

Verrucomicrobia use hundreds of enzymes to digest the algal polysaccharide fucoidan.

Andreas Sichert, Christopher H Corzett, Matthew S Schechter, Frank Unfried, Stephanie Markert, Dörte Becher, Antonio Fernandez-Guerra, Manuel Liebeke, Thomas Schweder, Martin F Polz and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 1 pooled it
37.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 1 synthesis or guideline pooled it, 323 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rafts of change: microbial and functional dynamics in simulatedApplied and environmental microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Andreas Sichert *Max Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-1386-5535
Christopher H Corzett *Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Matthew S SchechterMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-8435-3203
Frank UnfriedPharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Stephanie MarkertPharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0003-0923-3305
Dörte BecherMicrobial Proteomics, Institute of Microbiology, University of Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-9630-5735
Antonio Fernandez-GuerraMax Planck Institute for Marine Microbiology, Bremen, Germany.
Manuel LiebekeMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-2339-1409
Thomas SchwederPharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Martin F PolzDepartment of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9296-3733
Jan-Hendrik HehemannMax Planck Institute for Marine Microbiology, Bremen, Germany. jhhehemann@marum.de.ORCID http://orcid.org/0000-0002-8700-2564
Universität Greifswald · DEMax Planck Institute for Marine Microbiology · DEUniversity of Bremen · DEUniversity of Copenhagen · DKUniversity of Southern California · USUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown algae are important players in the global carbon cycle by fixing carbon dioxide into 1 Gt of biomass annually, yet the fate of fucoidan-their major cell wall polysaccharide-remains poorly understood. Microbial degradation of fucoidans is slower than that of other polysaccharides, suggesting that fucoidans are more recalcitrant and may sequester carbon in the ocean. This may be due to the complex, branched and highly sulfated structure of fucoidans, which also varies among species of brown algae. Here, we show that 'Lentimonas' sp. CC4, belonging to the Verrucomicrobia, acquired a remarkably complex machinery for the degradation of six different fucoidans. The strain accumulated 284 putative fucoidanases, including glycoside hydrolases, sulfatases and carbohydrate esterases, which are primarily located on a 0.89-megabase pair plasmid. Proteomics reveals that these enzymes assemble into substrate-specific pathways requiring about 100 enzymes per fucoidan from different species of brown algae. These enzymes depolymerize fucoidan into fucose, which is metabolized in a proteome-costly bacterial microcompartment that spatially constrains the metabolism of the toxic intermediate lactaldehyde. Marine metagenomes and microbial genomes show that Verrucomicrobia including 'Lentimonas' are abundant and highly specialized degraders of fucoidans and other complex polysaccharides. Overall, the complexity of the pathways underscores why fucoidans are probably recalcitrant and more slowly degraded, since only highly specialized organisms can effectively degrade them in the ocean.

Indexed as

Bacterial ProteinsCell WallEsterasesGenes, BacterialGlycoside HydrolasesMetabolic Networks and PathwaysMetagenomePhaeophyceaePhylogenyPolysaccharidesProteomeSubstrate SpecificitySulfatasesSulfatesTranscriptomeUnited StatesBacterial ProteinsEsterasesfucoidanGlycoside HydrolasesPolysaccharidesProteomeSulfatasesSulfates

Identifiers

PMID32451471
OpenAlexW3027509605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.